Zingone Bartolo, Rauber Elisabetta, Gatti Giuseppe, Pappalardo Aniello, Benussi Bernardo, Forti Gabriella, Tognolli Umberto, Gabrielli Marco
Cardiovascular Department, Cardiac Surgery Unit, Ospedali Riuniti di Trieste, Italy.
Eur J Cardiothorac Surg. 2007 Jun;31(6):990-7. doi: 10.1016/j.ejcts.2007.02.017. Epub 2007 Mar 26.
Severe atherosclerosis of the ascending aorta and arch frequently causes difficulties during heart operations, hindering surgical manoeuvres and potentially leading to systemic embolism. The aim of our study was to assess the safety and effectiveness of replacing the atherosclerotic ascending aorta in this setting.
Aortic atherosclerosis was characterized by epiaortic ultrasonographic scanning in 90.1% of 1927 consecutive adult patients undergoing cardiac operations, and by computed tomographic chest scanning in selected cases. Thirty-six of the 152 patients requiring major derangements from our standard practice due to aortic atherosclerosis underwent replacement of the ascending aorta and constitute the study group. Replacement of the aorta was extended to the arch in 13 cases (36.1%). It was associated with single or multiple valve surgery in 34 patients (94.4%) and with coronary revascularization in 30 (83.3%). Two patients (5.6%) underwent coronary bypass grafting without valve surgery. A cryoablation procedure was associated in three patients with permanent atrial fibrillation. Deep hypothermic circulatory arrest was employed in 34 patients (94.4%), while proximal aortic disease allowed conventional distal crossclamping in 2 cases. The risk of operative mortality was estimated by the logistic EuroSCORE both with and withholding the variable "surgery of the thoracic aorta". All survivors were followed-up for 1-41 months (16+/-12).
Two patients died in the hospital (5.6%) and two during follow-up, for a cumulative survival of 91.3% and 85.6% at 1 and 3 years, respectively (hospital deaths included). The hospital death rate compared favourably with the expected estimates of 25.5% (p<0.05) and 10.3% (p=0.67) obtained by the EuroSCORE full model and without "aortic surgery", respectively. In-hospital adverse neurologic events occurred in six patients (16.7%), including stroke in one patient (2.8%) and neurocognitive disturbances in five (13.9%), although they were all transient and cleared before discharge. Excess bleeding required re-exploration in four patients (11.1%), and one more patient underwent emergency grafting for acute postoperative coronary occlusion. Ten patients (38.5%) were intubated for longer than 24h.
Despite significant perioperative morbidity, replacement of the severely atherosclerotic aorta is worth consideration to avert expectedly higher death and stroke rates.
升主动脉和主动脉弓的严重动脉粥样硬化常给心脏手术带来困难,妨碍手术操作并可能导致全身性栓塞。我们研究的目的是评估在这种情况下置换动脉粥样硬化性升主动脉的安全性和有效性。
在1927例连续接受心脏手术的成年患者中,90.1%通过主动脉外超声扫描对主动脉粥样硬化进行特征性评估,部分病例通过胸部计算机断层扫描评估。152例因主动脉粥样硬化需要对我们的标准操作进行重大调整的患者中,36例接受了升主动脉置换,构成研究组。13例(36.1%)患者的主动脉置换延伸至主动脉弓。34例患者(94.4%)的主动脉置换与单瓣膜或多瓣膜手术相关,30例(83.3%)与冠状动脉血运重建相关。2例患者(5.6%)在未进行瓣膜手术的情况下接受了冠状动脉旁路移植术。3例患者在永久性心房颤动的治疗中接受了冷冻消融手术。34例患者(94.4%)采用了深低温停循环,2例患者因近端主动脉疾病可行传统的远端阻断。通过逻辑欧洲心脏手术风险评估系统(EuroSCORE)评估手术死亡率风险,分别纳入和不纳入“胸主动脉手术”变量。所有幸存者随访1 - 41个月(16±12)。
2例患者在住院期间死亡(5.6%),2例在随访期间死亡,1年和3年的累积生存率分别为91.3%和85.6%(包括住院死亡病例)。住院死亡率与欧洲心脏手术风险评估系统完整模型预期的25.5%(p<0.05)和不纳入“主动脉手术”变量预期的10.3%(p = 0.67)相比更有利。6例患者(16.7%)发生了住院期间不良神经事件,包括1例患者(2.8%)发生中风,5例患者(13.9%)发生神经认知障碍,不过这些症状均为短暂性,出院前均已消除。4例患者(11.1%)因出血过多需要再次手术探查,1例患者因术后急性冠状动脉闭塞接受了急诊血管移植术。10例患者(38.5%)插管时间超过24小时。
尽管围手术期发病率较高,但为避免预期更高的死亡率和中风发生率,置换严重动脉粥样硬化的主动脉仍值得考虑。